XELLIA PHARMACEUTICALS ApS
Xellia Pharmaceuticals ApS
Data as of 2026-09-27
GLEIF verified
Complete entity footprint
2 linked clusters ·
18 netblocks ·
1,417 IPv4 addresses ·
1 IPv6 prefixes
This organisation's clusters combined by evidence —
shared GLEIF corporate family
— not name similarity, so genuinely different organisations that share a name are excluded.
LEI
549300QZH7QG20ETC156
Registered name
XELLIA PHARMACEUTICALS ApS
Jurisdiction
Ultimate parent
Novo Nordisk Fonden
529900UTAHSVRYZL0380
This organisation
| Netblocks | 2 · 256 IPv4 addresses |
| IPv6 | 1 prefix (largest 2a12:a780::/32) |
| Record ID | 248081771 |
| Registry | BGP |
| Owner jurisdiction | DK |
| Customers | see who runs inside this network → |
Evidence & provenance ?
| Attribution | GLEIF legal-entity match |
| Legal identity | LEI 549300QZH7QG20ETC156 |
| Shared handles | clustered on 7 shared RIR contact/maintainer handles |
| Registry names | 2 distinct registrant names across these blocks |
| full provenance (JSON) → · how attribution works · report an issue | |
IP Ranges (2)
⬇ export CSV| CIDR | Org name | Registry | Status | Confidence |
|---|---|---|---|---|
| 94.143.227.0/24 | Xellia Pharmaceuticals ApS | BGP | ANNOUNCED | ● high |
| 2a12:a780::/32 | Xellia Pharmaceuticals ApS | RIPE | ALLOCATED-BY-RIR | ● low |
IPv6 ranges (1)
| CIDR |
|---|
| 2a12:a780::/32 |
Corporate group (2 confirmed entities)
+1 additional unconfirmed candidate not shown — full list (JSON)- NOVO COMMUNICATIONS LIMITED 16 blocks
Network trust
what's this?
RPKI hygiene: A
how networks compare →
100.0%
of checked blocks have valid RPKI ROA coverage
(3 of 3)
No discrepancies found among checked blocks.
NIC Handles
AS210418
DUMY-RIPE
DUMY-RIPE
ORG-XPA1-RIPE
RIPE-NCC-HM-MNT
XELLIA-MNT
XELLIA-MNT